AMKAF yields 3.01% · JNJ yields 2.13%● Live data
📍 AMKAF pulled ahead of the other in Year 1
Combined, AMKAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMKAF + JNJ for your $10,000?
A.P. Møller - Mærsk A/S operates as an integrated transport and logistics company worldwide. The company's Ocean segment engages in container shipping activities, including demurrage and detention, terminal handling, documentation and container services, and container storage, as well as transshipment services under Maersk Line, Safmarine, Sealand A Maersk Company, Hamburg Süd, and APM Terminal brands; and sale of bunker oil. Its Logistics & Services segment offers sea and air freight forwarding, supply chain management, cold chain logistics, and custom services, services. The company's Terminals & Towage segment is involved in Gateway terminal activities, and offshore towage, salvage and related marine activities under APM Terminals brand. Its Manufacturing & Others segment engages in the production of reefer containers; anchor handling tug supply vessels and subsea support vessels, and training services to the maritime, oil and gas, offshore wind, and crane industries. The company was founded in 1904 and is based in Copenhagen, Denmark.
Full AMKAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.